What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
Internal medicine, Cardiology, Myocardial infarction, Surgery and Angioplasty are his primary areas of study.
Bruce R. Brodie combines Internal medicine and MEDLINE in his studies.
In his research, Ischemia is intimately related to Prospective cohort study, which falls under the overarching field of Cardiology.
Bruce R. Brodie studied Myocardial infarction and Stroke that intersect with Risk factor, Killip class and Percutaneous.
The Stent, Restenosis, Embolization and Catheter research he does as part of his general Surgery study is frequently linked to other disciplines of science, such as C-reactive protein, therefore creating a link between diverse domains of science.
His Angioplasty research is multidisciplinary, incorporating elements of Reperfusion therapy and Primary angioplasty.
His most cited work include:
- Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial (1997 citations)
- American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) (1831 citations)
- Bivalirudin during Primary PCI in Acute Myocardial Infarction (1565 citations)
What are the main themes of his work throughout his whole career to date?
Bruce R. Brodie spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI.
His Internal medicine study frequently intersects with other fields, such as Surgery.
His research in the fields of TIMI, Primary angioplasty, Electrocardiography in myocardial infarction and Intravascular ultrasound overlaps with other disciplines such as In patient.
The Myocardial infarction study combines topics in areas such as Stroke and Angioplasty.
His Percutaneous coronary intervention research integrates issues from Myocardial infarction complications, Mortality rate and Coronary artery disease.
Bruce R. Brodie interconnects Platelet reactivity and Culprit in the investigation of issues within Conventional PCI.
He most often published in these fields:
- Internal medicine (85.22%)
- Cardiology (82.47%)
- Myocardial infarction (64.60%)
What were the highlights of his more recent work (between 2012-2018)?
- Internal medicine (85.22%)
- Cardiology (82.47%)
- Percutaneous coronary intervention (38.49%)
In recent papers he was focusing on the following fields of study:
Bruce R. Brodie mainly focuses on Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Conventional PCI.
His Internal medicine research includes elements of Surgery and Drug.
His Surgery research incorporates elements of Biomarker, Cohort study and Confounding.
The Cardiology study combines topics in areas such as Stent, Radiology, Prospective cohort study and Hazard ratio.
His Percutaneous coronary intervention study which covers Coronary artery disease that intersects with Coronary stent.
His work in the fields of Conventional PCI, such as Abciximab, overlaps with other areas such as Term.
Between 2012 and 2018, his most popular works were:
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study (565 citations)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study (238 citations)
- Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. (135 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Surgery.
His study in Revascularization, Bivalirudin, Conventional PCI, Hazard ratio and ST segment is carried out as part of his Internal medicine studies.
His Cardiology research includes themes of Stent, Prospective cohort study and Drug.
His research in Stent intersects with topics in Intravascular ultrasound and Thrombosis.
His biological study spans a wide range of topics, including Clopidogrel, Adverse effect and Renal function.
His Myocardial infarction research is multidisciplinary, relying on both Stroke, Randomized controlled trial and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
